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Abstract 
 The purpose of this study was to determine the effects of methamphetamine combined 
with hypoxia on the development and function of the cardiovascular system in Danio rerio 
embryos. It was hypothesized that the combined effect of the drug and decreased oxygen 
concentration would result in decreased cardiac parameters due to underdevelopment of the 
ventricle and vessels resulting from cardiomyopathy and lack of blood flow to tissues. It was 
found that methamphetamine exposure correlated to an increase in stroke volume, caudal 
artery and vein diameters and RBC velocities alone, while having a multiplicative effect of 
increasing arterial RBC velocity when combined with hypoxia. Methamphetamine exposure 
alone did not have a significant effect on heart rate and cardiac output. This experiment shows 
that the negative effects of prenatal abuse of methamphetamine could be amplified by hypoxia 
induced by various pathologies.   
Introduction 
Methamphetamine is a well-known, popularly abused central nervous system stimulant 
known to modify and possibly damage the cardiovascular system, increasing heart rate, blood 
pressure and blood glucose (Logan 2002). Long-term methamphetamine abuse has been linked 
to psychotic behavior (including hallucination and delusions similar to schizophrenia), motor 
and memory impairment (Nagai and Yamada 2010). Methamphetamine acts at the level of 
neuron synapse by increasing the release of neurotransmitters such as dopamine and serotonin 
into the synapse, while also blocking the reuptake of these neurotransmitters thus increasing 
activity in the brain (Won et. al 2013). Methamphetamine similarly acts on the heart to increase 
contractility and blood pressure by activating α- and β-adrenergic receptors in the cardiac 
muscle, as well as other cardiac pathologies including arrhythmias, sudden cardiac death and 
cardiomyopathy (Logan 2002, Won et. al 2013).   
While methamphetamine has been studied in detail in adults, little research has been 
done on its effect on fetal development (American College of Obstetricians and Gynecologists 
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2011). Several studies have shown children who have been prenatally exposed to 
methamphetamines have had significantly lower birth weight, smaller gestational age and 
increased possibility of defects in the cardiovascular, nervous and gastrointestinal systems 
(American College of Obstetricians and Gynecologists 2011). However, these studies were not 
corrected for the possibility of the mothers abusing other substances while pregnant. Prenatal 
methamphetamine exposure is also known to decrease uterine and placental blood flow, which 
is thought to be the cause of hypoxemia and hypertension in the fetus (Khoradmehr et. al 
2015). The methamphetamine-induced hypoxia to the fetus could then lead to decreased 
cardiovascular function due to many factors such as ventricle dilation, myocardial thinning, or 
septum defects (Patterson and Zhang 2010).  
This study was conducted to determine to what extent methamphetamine exposure 
combined with hypoxia exposure effects cardiovascular development. While 
methamphetamine exposure has the potential to increase the heart rate, potential significant 
underdevelopment of the heart resulting from a hypoxic environment would result in a 
decreased stroke volume, which in turn would cause decreased cardiac output, and RBC 
velocity. When exposed to methamphetamine or hypoxia alone, significant underdevelopment 
of the heart provides evidence that when combined, this effect would be amplified and cause a 
decrease in vessel diameter. This research will expand on that already performed on the effects 
of methamphetamine exposure during pregnancy on fetal growth, cognition, and behavior in 
humans and rats (Smith et al 2003, Vorhees et al. 1994). The zebrafish embryonic development 
is characteristic of most vertebrates, therefore any consequences observed in the experimental 
fish could be extended to the possible birth defects of children from mothers who abused 
methamphetamines while pregnant with the child and have lung/heart disease (Bakkers 2011). 
This research could be beneficial to providing insight into the possible physiological 
mechanisms of methamphetamines during embryogenesis and fetal development, and it 
effects on the human fetal cardiac morphology and physiology. 
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Methods 
Animals 
 Adult, long-finned zebrafish (Danio rerio) were used from breeding stock at the 
University of Akron Research Vivarium and bred to obtain embryos for exposure. The zebrafish 
model was chosen due to the similarities in cardiac development to other vertebrates, including 
humans, as well as the relative ease of breeding and experimentation, as zebrafish are 
characteristically transparent as embryos making them excellent models for microscopy 
(Bakkers 2011).  The adults were housed in 75L acrylic tanks at 26°C (±1°C) with a 14:10 hour 
light: dark cycle. Breeding boxes were introduced into the tanks just before the start of the dark 
cycle, breeding occurred just after the end of the dark cycle. The eggs were collected within one 
hour post fertilization (hpf) and immediately placed in a treatment flask (200mL) and incubated 
until 72 hpf.  
Chemicals 
Methamphetamine hydrochloride was obtained from Sigma Aldrich (lot number: 
SLBG3762V, item number: M8750) and the procedures for schedule II substances were 
followed. Exposures of 3.0mg/L intended for exposure were mixed the morning of egg 
collection. The solutions (control and experimental) were mixed with dechlorinated tap water.  
Treatment 
 Once the methamphetamine dilutions were created and separated into 200mL flasks, 
hypoxia was induced by bubbling the water with N2 gas (2.5 ± 0.5 mg O2/L) and normoxia was 
maintained via compressed air bubbles (7.0 ± 0.5 mg O2/L). The flasks were sealed with corks to 
minimize change in O2 concentrations. Once collected, 25 fertilized eggs were placed in the 
flasks in one of four treatments: normoxic conditions alone, normoxic conditions with 
methamphetamine (3.0 mg/L), hypoxia alone, or hypoxia with methamphetamine (3.0 mg/L). 
Two flasks were used for each treatment. After 24 hours, the embryos were temporarily 
removed from the flasks so that the dead embryos could be removed and the water could be 
changed and replaced with identical treatment dilution solutions and oxygen concentrations. 
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The embryos were placed back in the same treatment flask. At 72 hpf, the water was changed a 
second time, but replaced instead with dechlorinated tap water and normoxic conditions in all 
flasks. At this time, the majority of the larvae had hatched and data collection began.  
Measurement 
 For data collection, the larvae were placed in 1mL dechlorinated wells and placed under 
an inverted light microscope (Leica DMIRB) with a temperature-controlled stage (Harvard 
Apparatus). 5-second videos were recorded using a high-speed camera (Red Lake MASD, 125 
frames/second) of both the heart and of the trunk vessels of the tail of each larva. Image Pro 
Software (version 4.5) was used to measure cardiac parameters, including heart rate, stroke 
volume, RBC velocity and trunk vessel diameter using the digital motion technique, as described 
by Schwerte and Pelster (2000).  
 For each embryo, using approximately 800 frames of the trunk vessel video, a cast was 
taken using the digital motion technique to measure the arterial and venous diameters by 
drawing five lines across the trunk artery and vein, a technique derived from Bagatto (2005). 
The frames were used to measure arterial and venous RBC velocity by taking the differential of 
the frames and measuring the length of seven blood cells at peak flow, which is equivalent to 
the length each cell moved per 1/125 of a second.   
 The heart rate was measured with a five second video of the heart, where the number 
of frames between each contraction was counted for three beats. The area and greatest width 
of the ventricle was measured using Image Pro software at systole and diastole for three 
heartbeats. These values were used to calculate ventricular volume using the following 
equation described by Bagatto and Burggren (2006):  
Ventricular volume = (8A2)/(3πL) 
Where A is equivalent to the ventricular area at either systole or diastole, and L is the length of 
the ventricle. This equation determined end systolic volume (ESV) and end diastolic volume 
(EDV), which were used to calculate stroke volume (SV) by subtracting ESV from EDV. The 
stroke volume was multiplied by heart rate (HR) to calculate overall cardiac output (Q).  
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Statistics 
 First, a one-way nested analysis of variance (ANOVA) was performed to test for variance 
between treatment flasks. No significant variance from flask effects was measured. Therefore, 
the cardiovascular parameters (vessel diameter, RBC velocity, SV, heart rate, and Q) were 
analyzed using a crossed two-way ANOVA to test the main effects of oxygen concentration and 
methamphetamine. (Appendix A, Table 1-2). When significance in any of the main effects was 
found with the ANOVA, a post hoc Fisher’s LSMeans Difference multiple comparison test was 
conducted to determine the source of significance (Appendix A, Table 3-4). Statistics were 
performed using JMP Pro 13 (SAS institute) with alpha set at p < 0.05.  
 
Results 
Stroke Volume 
 Stroke volume (SV) was measured by subtracting ESV from EDV at 72hpf for all 
treatment groups. Oxygen concentration had a slight effect on ESV (F ratio=3.26, p=0.0764), 
and methamphetamine exposure had a slight effect on EDV (F ratio=1.98, p=0.0759). 
Methamphetamine exposure had a significant effect on stroke volume (F ratio=5.36, p=0.024), 
shown Figure 1A-C. The post hoc analysis showed a significant increase in both EDV and SV with 
methamphetamine and hypoxia co-exposure compared to the normoxic group not exposed to 
methamphetamine.  
Heart Rate 
 The heart rate (HR), shown in Figure 1D, measured in beats per minute (bpm), was 
measured at 72 hpf for all treatment groups. While no significance was found with 
methamphetamine exposure (F ratio=1.75, p=0.1911), oxygen concentration had a significant 
effect on heart rate (F ratio=4.64, p=0.0355). The post hoc analysis showed a significant 
increase in heart rate in the hypoxia group not exposed to the drug compared to the normoxia 
methamphetamine co-exposed group.  
Cardiac Output 
 No significant effect of oxygen concentration or methamphetamine exposure was 
determined with the ANOVA (F ratio=1.45, p=0.2329 and F ratio=3.70, p=0.0595, respectively). 
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However, the post hoc analysis showed a significant increase in cardiac output between the 
hypoxia and methamphetamine co-exposed group compared to the normoxia group not 
exposed to the drug.  
Artery Diameter 
  Exposure to methamphetamine had a significant effect on caudal artery diameter (F 
ratio=4.10, p=0.0476), while the oxygen concentration showed no significant change in 
diameter (F ratio=0.18, p=0.6690). No significance was found in the post hoc analysis for the 
source of the effect.  
Vein Diameter 
 Vein diameter was significantly affected by methamphetamine exposure alone (F 
ratio=5.06, p=0.0285). Interestingly, the post hoc LSMeans Difference test showed a slight 
increase in diameter with co-exposure to hypoxia and methamphetamine (p=0.0797), leading 
to a 16.2% increase in vein diameter of the hypoxic, methamphetamine-exposed fish compared 
to the hypoxia group not exposed to the drug, shown in Figure 2B.  
Arterial RBC Velocity 
 The red blood cell velocity was measured in the caudal vessels for all treatment groups 
at 72 hpf. While no effect was measured between the oxygen concentration treatments (F 
ratio=1.52, p=0.2216), methamphetamine exposure had a significant effect on RBC velocity in 
the caudal artery (F ratio=15.1, p=0.0003). A significant interaction was also found between the 
oxygen concentration and methamphetamine co-exposure (F ratio=5.35, p=0.0244). The post 
hoc LSMeans Difference test showed an increase in arterial RBC velocity with hypoxia and 
methamphetamine co-exposure compared to the normoxic group not exposed to 
methamphetamine and as well as an increase with co-exposure compared to the hypoxia group 
not exposed to the drug (see Figure 2C).  
Venous RBC Velocity 
 Oxygen concentration had no effect on RBC velocity in the caudal vein (F ratio=0.027). 
However, exposure to methamphetamine had a significant effect on venous RBC velocity (F 
ratio=9.02, p=0.0040). While the ANOVA did not show a significant interaction (F ratio=0.2979, 
p=0.5874), the post hoc analysis showed a significant increase in RBC velocity in the vein 
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between the normoxia and methamphetamine co-exposed group compared to the hypoxia 
group not exposed to the drug and from the normoxia group not exposed to the drug.  
 
 
  Figure 1. End Diastolic Volume (EDV), End Systolic Volume (ESV), Stroke Volume, Heart Rate and 
Cardiac Output (Q) for all treatment groups, recorded at 72 hpf. Sample sizes are noted on the 
bars, and error bars represent standard error. Bars not connected by the same letter are 
significantly different (significance determined by post hoc Fisher’s LSD test). (A) EDV and (B) 
ESV were both unaffected by either treatment. (C) Stroke Volume only slightly increased from 
the normoxia control when meth and hypoxia were combined. (D) Heart rate was unaffected by 
methamphetamine, but significantly increased with hypoxia compared to the normoxia control. 
(E) Q was unaffected by either exposure.  
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Figure 2. Caudal vessel diameters (A-B) and caudal vessel RBC velocities (C-D) of all treatment 
groups recorded at 72 hpf. Sample sizes are noted on the bars, error bars represent standard 
error. Bars not connected by the same letter are significantly different (significance determined by 
post hoc Fisher’s LSD test). (A) Artery diameter increased with methamphetamine exposure 
compared to the unexposed embryos. (B) Vein diameter was unaffected by methamphetamine 
exposure but did increase with hypoxia when compared to the normoxia control. (C). Arterial RBC 
velocity significantly increased when methamphetamine and hypoxia were combined compared 
to the normoxia control. (D) Venous RBC velocity was unaffected by exposure to hypoxia, but did 
increase significantly compared to the unexposed treatment groups when exposed to 
methamphetamine.   
   A            AB                                    B            AB 
     A            AB                                    C             BC 
        AB           A                                     BC            C 
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Discussion 
 The cardiovascular system function was shown to be affected by embryonic 
methamphetamine exposure until 48 hpf. While drug exposure showed no significant effects on 
heart rate or cardiac output, there were significant effects on stroke volume, artery and vein 
diameter, and arterial and venous RBC velocity. The results contradicted the hypothesis.  
In the human fetus, methamphetamine is known to act on the heart, resulting in 
ventricular myopathy and cardiac underdevelopment such as myocardial thinning, septum 
defects and smaller ventricular volume (Patterson and Zhang 2010). It was hypothesized that 
methamphetamine exposure would significantly decrease the stroke volume and cardiac 
output when combined with hypoxia (Patterson and Zhang 2010, Smith et al 2003, Vorhees et 
al. 1994). However, stroke volume significantly increased (Figure 1C) along with a slight increase 
in cardiac output (Figure 1E). End diastolic volume increased slightly, possibly due to increased 
ventricular compliance or increased preload, which can increase the volume of blood entering 
the ventricle thus increasing the volume pumped out (Klabunde 2012). As methamphetamine 
exposure could result in ventricular thinning (Patterson and Zhang 2010), compliance resulting 
from a thinner myocardium in the ventricle could have increased resulting in a greater volume 
of blood capable of entering the ventricle to be pumped out. Preload on the ventricle could 
have been increased by a higher aortic blood pressure resulting from the methamphetamines 
acting on the vessel α-adrenergic receptors stimulating a “flight or fight” response (Logan 
2002). The increase in stroke volume with methamphetamine exposure is a contributor to the 
slight increase in cardiac output, while a second contributor is also the increased heart rate 
with hypoxia exposure (Figure 1D). This effect of hypoxia on heart rate was surprising, as 
research indicates that cardiac contractility would decrease in response to hypoxia and result in 
bradycardia (Patterson and Zhang 2010, Klabunde 2012). These results could be suggestive of a 
relatively small sample size, as a power analysis shows that doubling the sample size will nearly 
double the power of the analysis (see Appendix A, Table 5).  
Methamphetamine exposure had significant effects on artery and vein diameters, as 
well as on RBC velocity in the caudal artery and vein. While it was hypothesized that the 
vasoconstrictive properties of methamphetamine would override the vasodilatory effects of 
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hypoxia and result in a decrease in vessel diameter, the opposite was discovered (Figure 2A-B) 
(Logan 2002, Klabunde 2012). Hypoxia results in vasodilation of the tissue vessels to increase 
flow and perfusion to the tissues in response to a decrease in oxygen concentration via release 
of nitric oxide, endothelial-derived hyperpolarizing factor (EDHF) and prostacyclin, all of which 
inhibit smooth muscle contraction resulting in vasodilation (Klabunde 2012). Conversely, 
methamphetamine acts on the α-adrenergic receptors of smooth muscle, causing the release of 
endothelin-1 (ET-1), which is a powerful vasoconstrictor (Logan 2002, Won et. al 2013, 
Klabunde 2012). Due to the significantly larger arterial and venous vessel diameters, it could be 
hypothesized that the vasoconstrictive effects of methamphetamine were outcompeted by the 
vasodilatory effects of hypoxia. However, this mechanism would need further study, as 
Schwerte et. al (2006) found that - and -adrenergic receptors in fish larvae are present but 
inactive until approximately 4 days post-fertilization. This means that the exact mechanism of 
action methamphetamine has on the heart of 72 hpf larvae could be more complex than 
originally thought, as the receptors are not active and would therefore be insensitive to 
methamphetamine to alter vasoactive motion of the vessels.  
Methamphetamine exposure had a significant effect on arterial and venous RBC velocity 
(Figure 2C-D). The RBC velocity in the caudal artery was also significantly increased when 
methamphetamine exposure was combined with hypoxia exposure, suggesting a multiplicative 
interaction. Klabunde (2012) explains Poiseuille’s equation as blood flow (or velocity) being 
proportional to the radius of the vessel to the power of 4 (Fr4). The vascular response to 
hypoxia results in vasodilation, which would exponentially increase flow and velocity in 
accordance to Poiseuille’s equation. However, methamphetamine’s vasoconstrictive properties 
via α-adrenergic receptor activation could result in a decrease in flow, opposing the 
vasodilatory effects of hypoxia. Rather than the opposing forces cancelling out, the 
vasoconstriction effect could have been surpassed by the increase in vessel diameter, which has 
a more significant effect on velocity than pressure alone (Klabunde 2012), or due to the inactive 
-adrenergic receptors in the vessels giving no vasoconstrictive response to methamphetamine 
(Schwerte et. al 2006). The significant interaction of hypoxia and methamphetamine co-
exposure on arterial RBC velocity could be caused by a combination of the vasodilatory 
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response to hypoxia and the increase in blood pressure and cardiac output in response to 
methamphetamine.  
The functionality of the cardiac system is key to whole body development in any 
organism, as its purpose is to generate pressure to perfuse tissues with oxygen and nutrients 
(Klabunde 2012). With impeded flow, the tissue may fail to develop properly. In human infants, 
prenatal methamphetamine exposure resulted in smaller head circumference, reduced brain 
volume and lower birth weight, all possibly resulting in poorly developed tissue due to 
variations in cardiac function and blood flow (American College of Obstetricians and 
Gynecologists 2011, Klabunde 2012). Methamphetamine exposure in adult rats resulted in 
accelerated glucose and fatty acid catabolism, and could also be shown to act similarly on the 
systemic metabolism of other mammals with further study (Zheng et. al 2014). Therefore, if the 
metabolic demand of embryos exposed to methamphetamines increases, the flow of blood to 
the metabolizing tissues must increase as well to supply the tissue with nutrients needed to 
support the metabolic demand. The underlying response to hypoxia and methamphetamine 
exposure would then be to increase cardiac parameters such as stroke volume, heart rate, 
vessel diameter and RBC velocity to maintain the delivery of oxygen and nutrients to the 
metabolizing tissue while in a low oxygen environment.  
Conclusions 
As the results have shown, methamphetamine exposure has significant effects on 
cardiovascular function, and in several cases a multiplicative effect when combined with 
hypoxia. Oxygen concentration significantly affected heart rate, while methamphetamine 
exposure had an effect on stroke volume, caudal artery and vein diameter, and arterial and 
venous RBC velocity. EDV, ESV, and Cardiac output were unaffected by either exposure. A 
multiplicative effect of co-exposure to hypoxia and methamphetamine was found in arterial 
RBC velocity. These results show that while several cardiac parameters were altered due to the 
individual effects of hypoxia or methamphetamine, combined exposure can synergistically act 
on the cardiovascular system.  
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This study could have been improved by increasing the sample sizes (shown with a 
power analysis of the results where the p-value was between 0.07 and 0.059, see Appendix A, 
Table 4) of the treatment groups, thus increasing the accuracy of the results depicting changes 
in the cardiovascular system in response to co-exposure as well as the reliability of the results 
without the action of confounding effects. Exposure of the embryos could have been altered by 
lengthening methamphetamine exposure to 72 hpf, or by performing multiple water changes 
daily to ensure constant methamphetamine exposure as well as oxygen concentrations. The 
dosage of methamphetamine could also be increased to determine if increased 
methamphetamine concentration could further effect the cardiac development. This area of 
research could also benefit from simultaneous exposure of methamphetamine combined with 
other popularly abused drugs, such as nicotine or heroine, and their effects on cardiac 
parameters, as it better reflects the reality of pregnant women abusing multiple drugs while 
pregnant, as it is becoming a more common occurrence (American College of Obstetricians and 
Gynecologists 2011). 
 In Ohio alone, the availability of methamphetamine is a 10 on a 0-10 scale (0 being not 
available and 10 being extremely easy to get), and the use of the drug is on the rise according to 
the Ohio Department of Mental Health and Addiction Services (2016).  This poses a large risk, as 
53% of the methamphetamine users were female, and of those more than 50% were of child-
bearing age (Ohio Department of Mental Health and Addiction Services 2016). There is a risk of 
these women abusing methamphetamines while pregnant, which would pose a serious risk to 
the cardiovascular functionality of the fetus. As the results suggested, if any of these women 
were at risk for or diagnosed with COPD, anemia, or other heart disease resulting in hypoxemia 
it could amplify the effects of methamphetamine on their unborn child and intensify the 
negative side effects. Further research is needed to fully understand and map out the exact 
mechanism of methamphetamine in the embryo to fully understand its effects.  
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Appendix A 
 
Main Effects ANOVA results (Parameter Estimates): 
A. ESV 
 
B. EDV 
 
C. Stroke Volume 
 
D. Heart Rate 
 
E. Cardiac Output 
 
 
Table 1. The results of the main effects ANOVA on cardiac parameters, showing both the parameter estimates and the effects tests. The F ratio 
values and p-values for main effects were taken from the effects tests. (A) End Systolic Volume, (B) End Diastolic Volume, (C) Stroke 
Volume, (D) Heart Rate, (E) Cardiac Output.   
 
A. Arterial Diameter 
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B. Venous Diameter 
 
 
C. Arterial RBC Velocity 
 
 
 
D. Venous RBC Velocity 
 
 
 
Table 2. The results of the main effects ANOVA on vascular parameters, showing both the parameter estimates and the effects tests. The F ratio 
values and p-values were taken from the effects tests. (A) Caudal Artery Diameter, (B) Caudal Vein Diameter, (C) Arterial RBC 
Velocity, (D) Venous RBC Velocity.  
 
Post hoc Analysis results where significance was found in co-exposure: 
A. ESV            B. EDV   C. SV 
 
D. HR           E. Q  
 
Table 3. The post hoc LSMeans Difference test values for 
(A) End Systolic Volume, (B) End Diastolic Volume, (C) 
Stroke Volume, (D) Heart Rate, and (E) Cardiac Output 
where a significant effect was measured between the main 
effects. Levels not connected by the same letter are 
significantly different. (where H is hypoxia, N is normoxia, 
M is methamphetamine and C is control [no 
methamphetamine exposure]).   
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Power Analysis Tables where 0.080< p >0.0595: 
A. ESV 
α σ δ Number Power 
0.0500 0.000177 4.123e-5 60 0.4265 
0.0500 0.000177 4.123e-5 120 0.7164 
 
B. EDV 
α σ δ Number Power 
0.0500 0.000216 5.042e-5 60 0.4278 
0.0500 0.000216 5.042e-5 120 0.7180 
 
C. Cardiac Output 
α σ δ Number Power 
0.0500 13.51429 3.35663 60 0.4725 
0.0500 13.51429 3.35663 120 0.7698 
 
D. Venous Diameter 
α σ δ Number Power 
0.0500 1.555417 0.358411 60 0.4186 
0.0500 1.555417 0.358411 120 0.7065 
 
Table 5. The power analysis values for all measurements where the ANVOA showed a p value between 0.070 and 0.059. The sample size was 
increased from n=60 to n=120 and the power analyzed for improvement in data to reject or confirm the hypothesis. An increase in power is 
considered improvement. (A) End Systolic Volume with respect to oxygen concentration, (B) End Diastolic Volume with respect to 
methamphetamine exposure, (C) Cardiac Output with respect to co-exposure to hypoxia and methamphetamine, (D) Caudal Vein Diameter 
with respect to the co-exposure to hypoxia and methamphetamine.  
Table 4. The post hoc LSMeans Difference test  
values for (A) Artery Diameter, (B) Vein Diameter, 
(C) Arterial RBC Velocity, and (D) Venous RBC 
Velocity where a significant effect was measured 
between the main effects. Levels not connected 
by the same letter are significantly different. 
(where H is hypoxia, N is normoxia, M is 
methamphetamine and C is control [no 
methamphetamine exposure]).   
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